A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis.
about
A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@en
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@nl
type
label
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@en
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@nl
prefLabel
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@en
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@nl
P2093
P2860
P356
P1476
A phase 2 study of simtuzumab ...... hrombocythaemia myelofibrosis.
@en
P2093
Jason Gotlib
Jeffrey Silverman
Julia D Maltzman
Ruben A Mesa
Shringi Sharma
Stephen T Oh
P2860
P304
P356
10.1111/BJH.14501
P407
P577
2017-02-21T00:00:00Z